Navigation Links
Inflammation Molecule May Determine Fat Levels
Date:3/24/2010

Link only seen in normal-weight women, suggesting it protects against obesity

WEDNESDAY, March 24 (HealthDay News) -- Swedish scientists have discovered that a well-known marker of inflammation may help determine how much fat tissue people carry around.

But the relationship was not present in obese individuals, according to the research, which appears in a letter to the editor in the March 25 issue of the New England Journal of Medicine.

"There seems to be a certain feedback in patients with normal weight that's not there with patients who have obesity," said Dr. Jacob Warman, chief of endocrinology at The Brooklyn Hospital Center in New York City. "This tells us that [this inflammatory marker] seems to be protective."

"The real question people have been asking is why is heavy bad? Elephants are large and don't die of heart disease. They're meant to be big," said Dr. Mitchell Roslin, chief of bariatric surgery at Lenox Hill Hospital in New York City and Northern Westchester Hospital in Mt. Kisco, N.Y. "Being big doesn't make you ill or sick, so the question is why does this go on?"

Obesity, which contributes to a range of health ills, has emerged as one of the most pressing public health problems in the world today, although researchers are still trying to untangle exactly why obesity and disease go hand-in-hand.

"For years, we thought of fat as a dormant storer of energy, and now we realize that the fat cells are much more dynamic. They're much more active and much more involved in many processes," Roslin said. "Essentially obesity is an inflammatory state. Obesity activates the immune system and makes [people's bodies] behave as if they're inflamed."

And that leads to the various complications of obesity, such as heart disease.

These authors, from the renowned Karolinska Institute in Stockholm, Sweden, did a test-tube experiment of fat tissue taken from 23 lean, premenopausal women aged 26 to 49.

The investigators found that levels of tumor necrosis factor-alpha (TNF-a) were heightened in these normal-sized women. The women also had fewer but larger fat cells, as opposed to many more small fat cells.

But when looking at 26 obese healthy women of roughly the same age, the researchers found no relationship between TNF-a and body fat or body mass index (a measurement that is based on height and weight).

Tumor necrosis factor is a cytokine that contributes to inflammation. It has been implicated in a number of diseases, including rheumatoid arthritis.

According to the authors, TNF-a changes how fat tissue works and contributes to some of the metabolic problems associated with diabetes.

Still, there are a number of questions not answered by the study.

One is whether the relationship or lack thereof would hold true in older individuals.

Also, the authors only looked at surface fat, not the visceral fat deeper inside the body that is more closely associated with heart disease, Warman said.

"That would have meant putting a needle in the belly and taking out the fat tissue. That's really more invasive," Warman said.

More information

The U.S. Centers for Disease Control and Prevention has more on obesity.



SOURCES: Jacob Warman, M.D., chief, endocrinology, The Brooklyn Hospital Center, New York City; Mitchell Roslin, M.D., chief, bariatric surgery, Lenox Hill Hospital, New York City, and Northern Westchester Hospital, Mt. Kisco, N.Y.; March 25, 2010, New England Journal of Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Inflammation marker related to obesity is elevated in patients with pancreatic cancer
2. New Laser Relieves Pain and Inflammation
3. Yoga reduces cytokine levels known to promote inflammation
4. Thyme oil can inhibit COX2 and suppress inflammation
5. Cooling inflammation for healthier arteries
6. Targeted delivery of losartan reduces liver inflammation and scarring
7. Targeting blood vessels, immune system may offer way to stop infection-caused inflammation
8. Molecule Discovery Might Help ALS Patients
9. Stress -- From molecules to behavior
10. Wayne State Researchers Report a Possible Proofreading Step in DNA Synthesis by Observing Single Molecules of DNA Polymerase
11. Scientists Link Molecule to Severe Swine Flu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental ... Your Mouth?” (WIYM) campaign to inform dentists and patients about the safety issues related ... and prosthetic market in the U.S. is projected to reach $6.4 billion in 2018 ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... was set up in 2006 as a non-profit organization to unite pharmaceutical and ...
(Date:12/8/2016)... ... 08, 2016 , ... Healthcare is in flux. The GOP ... the mass media launching of story movements to highlight what's most unfair about ... experiences; such a movement can generate the network power to improve healthcare policies ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp Insurance, an ... around the greater Phoenix metropolitan region, is announcing a charity event to provide ... the Homeless Youth Connection is to promote community awareness of the ongoing needs ...
(Date:12/7/2016)... ... 07, 2016 , ... DrugDev again demonstrated its dedication to reducing ... the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department of Commerce. ... sides of the Atlantic with a mechanism to comply with EU data protection requirements ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016   TriNetX , the health research ... signed a membership agreement to join the ... new cures. The TriNetX network is ... patients globally, biopharmaceutical companies and contract research organizations ... design, site selection, patient recruitment, and collaborative research ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals International, ... VRX) ("Valeant") today announced positive results from a ... to assess the safety and efficacy of IDP-118 ... of plaque psoriasis. Within the ... moderate to severe psoriasis, IDP-118 showed statistical significance ...
(Date:12/8/2016)... 8, 2016  EIP Pharma, LLC ( www.eippharma.com ... for neflamapimod (previously code named VX-745), with the ... trials that demonstrated significant Alzheimer,s disease relevant pharmacological ... and Study 303 (6-week treatment) are the subject ... Disease (CTAD) scientific conference in San ...
Breaking Medicine Technology: